A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied

• Status: Terminated
• Trial end date: 2015-11-01

Summary

The purpose of this trial is to test the safety and tolerance of the combination therapy with cytarabine, lomustine and radiotherapy in patients with leptomeningeal metastasis from malignant melanoma.

• Phase: Phase 1

Details

• Lead Sponsor: University Hospital, Bonn
• Collaborator: Mundipharma Research GmbH & Co KG
• Treatments: Cytarabine; Lomustine